Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prabhavathi Fernandes Insider Profile
4 Followers
Prabhavathi Fernandes, President & CEO, Director at Melinta Therapeutics, holds 495.36K shares in Melinta Therapeutics (Ticker: MLNTQ), holds ― shares in Ocugen (Ticker: OCGN), holds ― shares in OpGen (Ticker: OPGN).
Prabhavathi Fernandes Melinta Therapeutics (MLNTQ)President & CEO, Director
Melinta Therapeutics (MLNTQ)
President & CEO, Director
Ranked #9,247 out of 78,624 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+288.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Prabhavathi Fernandes does not currently own shares as a corporate insider.
A breakdown of Prabhavathi Fernandes's holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Melinta Therapeutics
(MLNTQ)
(MLNTQ)
Rating:Informative Buy
Date:May 15, 2014 - May 15, 2015
Return:+294.60%
The most profitable trade made by Prabhavathi Fernandes
Prabhavathi Fernandes's Trading History
Melinta Therapeutics
May 27, 2015
―
Uninformative Sell
321.48K
$54.49K
Ocugen
―
Director
―
―
OpGen
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Prabhavathi Fernandes's performance on stock
You May Also Like
Prabhavathi Fernandes insider profile FAQ
What is the percentage of profitable transactions made by Prabhavathi Fernandes?
The percentage of profitable transactions made by Prabhavathi Fernandes is 100%.
What is the average return per transaction made by Prabhavathi Fernandes?
The average return per transaction made by Prabhavathi Fernandes is 288.30%.
What stocks does Prabhavathi Fernandes hold?
Prabhavathi Fernandes holds: MLNTQ, OCGN, OPGN stocks.
What was Prabhavathi Fernandes’s latest transaction?
Prabhavathi Fernandes latest transaction was an Uninformative Sell of $321.48K.
What was Prabhavathi Fernandes's most profitable transaction?
Prabhavathi Fernandes’s most profitable transaction was an Informative Buy of MLNTQ stock on May 15, 2014. The return on the trade was 294.60%.
What is Prabhavathi Fernandes's role in Melinta Therapeutics?
Prabhavathi Fernandes's role in Melinta Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.